Panacea Biotec Ltd — Quarterly Results & Earnings

₹296.05

-2.65%

Profit Growth YoY-905.95%Latest quarter

Sales Growth YoY-4.22%Latest quarter

Sales CAGR 5Y0.55%5 year compound

Profit CAGR 5Y11.74%5 year compound

📋

Quarterly Performance

YoY Profit Growth-905.95%

🔴 Significant decline

YoY Sales Growth-4.22%

⚠️ Mild contraction

OPM 5Y Average

Operating profit margin

-2.59%

EPS Growth 5Y

11.74%

Interest Coverage

Higher = safer debt servicing

-9.49

ROE

-4.92%

ROCE

-4.57%

💡

Growth Analysis

Panacea Biotec Ltd reported YoY profit growth of -905.95% and revenue growth of -4.22% in the latest quarter. Significant profit decline — requires close monitoring. Over 5 years, sales compounded at 0.55% and profits at 11.74% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Panacea Biotec Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.